Skip to main content Skip to main navigation menu Skip to site footer

Hubungan antara osteopontin dengan rasio Ca : Mg dan nilai Ca X P: Studi pada penderita penyakit ginjal tahap akhir



Abstract

Background: End-stage renal disease (ESRD) can impair mineral metabolisms in the human body, such as calcium (Ca), magnesium (Mg), and phosphate (P). Osteopontin is released by the kidneys and inhibits vascular calcification. Examination of the Ca:Mg ratio and Ca x P product in ESRD to see vascular calcification complications and is considered better than a single examination.

Objective: To analyze the correlation of osteopontin levels with the ratio of Ca: Mg and product Ca x P in ESRD patients.

Methods: Analytic observational study with cross sectional approach was conducted in February-June 2019 involving 30 ESRD patients while hemodialysis at Permata Medika Hospital in Semarang with consecutive sampling. They were screened according to the inclusion and exclusion criteria. Calcium, magnesium and phosphate levels were measured using K lite cornley with the Ion-Selective Electrode (ISE) method. The Ca:Mg ratio and Ca x P product were calculated manually. Osteopontin levels were measured using the ELISA method. Correlation using Spearman test with p<0.05 was considered significant.

 Results: The median Ca:Mg ratio was 4.63 (3.27 - 5.58) and the Ca x P product was 58.26 mg2/dl2 (19.53 - 111.24). Correlation of osteopontin with Ca:Mg ratio and Ca x P product are respectively with r=0.370 (p=0.044) and with r=0.406 (p=0.026).

Conclusion: Osteopontin is correlated to the level of Ca:Mg ratio and Ca x P product in ESRD patients.

 

 

Latar belakang: Penyakit ginjal tahap akhir (PGTA) dapat mempengaruhi metabolisme mineral, seperti kalsium (Ca), magnesium (Mg), dan fosfat (P). Osteopontin yang dikeluarkan oleh ginjal berfungsi menghambat kalsifikasi vaskuler. Pemeriksaan rasio Ca:Mg dan nilai Ca x P pada PGTA untuk melihat komplikasi kearah kalsifikasi pembuluh darah dan dianggap lebih baik daripada pemeriksaan tunggal.

Tujuan: Menganalisis korelasi kadar osteopontin dengan rasio Ca:Mg dan nilai Ca x P pada pasien PGTA.

Metode: Penelitian observasional analitik dengan pendekatan potong lintang dilakukan pada bulan Februari-Juni 2019 melibatkan 30 pasien PGTA saat melakukan hemodialisis di RS Permata Medika Semarang yang memenuhi kriteria inklusi dan ekslusi dengan teknik consecutive sampling. Kadar kalsium, magnesium dan fosfat diukur menggunakan alat K lite cornley dengan metode Ion Selective Electrode (ISE) dan rasio Ca:Mg dan Ca x P dihitung manual. Pemeriksaan kadar osteopontin menggunakan metode ELISA. Analisis statistika menggunakan uji Spearman dengan p<0,05 dianggap bermakna.

Hasil: Hasil median rasio Ca:Mg adalah 4,63 (3,27 – 5,58) dan nilai Ca x P adalah  58,26 mg2/dl2 (19,53 – 111,24). Korelasi osteopontin dengan rasio Ca:Mg dan nilai Ca x P berturut-turut adalah r= 0,370 (p=0,044) dan r=0,406 (p=0,026).

Simpulan: Kadar osteopontin berkorelasi dengan rasio Ca:Mg dan nilai Ca x P pada pasien PGTA.

Keywords: PGTA osteopontin rasio Ca Mg nilai Ca x P

References

  1. National Institute for Health and Care Excellence. Chronic kidney disease in adults: assessment and management. NICE. 2014;CG182:1-60 https://www.nice.org.uk/guidance/cg182.
  2. Pusat Data dan Informasi Kementerian Kesehatan RI. Situasi penyakit ginjal kronis. Kemenkes RI. 2017;01-10.
  3. Arifa SI, Azam M, Handayani OWK. Faktor yang berhubungan dengan kejadian penyakit ginjal kronik pada penderita hipertensi di Indonesia. Jurnal MKMI. 2017;13(4):319-328 http://dx.doi.org/10.30597/mkmi.v13i4.3155
  4. Faraji1 AH, Anwar MR, Debnath DK, Alam B, Morshed SM, Hasan KM. Serum cystatin c as an endogenous marker of renal function in patients with chronic kidney disease (CKD). J Curr Adv Med Res. 2017;4(1):3-12 http://www.banglajol.info/index.php/JCAMR
  5. USRDS Annual data report. Atlas of End-Stage Renal Disease in the United States. 2012;2:193-259
  6. Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2014;1-16 https://doi.org/10.2215/CJN.09750913
  7. Saha M, Faroque M, Alam KS, Alam MM, Ahmed S. Chronic kidney disease specific cardiovascular risk factors among non dialytic patients with chronic kidney disease stage-V–An experience of a specialized hospital. Bangladesh Med Res Counc Bull. 2012;38:18-22 DOI: 10.3329/bmrcb.v38i1.10447
  8. Sase SP, Ganu JV, Nagane N. Osteopontin: A Novel Protein Molecule. Indian Medical Gazette. 2012;146(2):62-66. http://medind.nic.in/ice/t12/i2 /icet12i2p62.pdf
  9. Lorenzen J, Kramer R, Kliem V, Boeger STB, Veldink H, Haller H, et al. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Invest. 2010;40(4):294–300. DOI: 10.1111/j.1365-2362.2010.02271.x
  10. Ziniewicz HK, Gesteiro E, Muñoz MJG, Sara Bastida S, Sánchez FJ. Relationships between serum calcium and magnesium levels and lipoproteins, homocysteine and insulin resistance/sensitivity markers at birth. Nutr Hosp. 2015;31:278-285. DOI: 10.3305/nh.2015.31.1.8007
  11. Dai Qi, Shu X.U, Deng X, Xiang YB, Li H, Yang G et al. Modifying effect of calcium/magnesium intake ratio and mortality: a population based cohort study. BMJ Open. 2013;3:1-7. http://dx.doi.org/10.1136/bmjopen-2012-002111
  12. Phosphate Binders Therapeutic Class Review. Magellan Rx Management. 2016;1-16.
  13. Sato H, Takeuchi Y, Matsuda K, Saito A, Kagaya S, Fukami H et al. Evaluation of the predictive value of the serum calcium-magnesium ratio for all-cause and cardiovascular mortality in incident dialysis patients. Cardiorenal Med. 2018;8:50–60. https://doi.org/10.1159/000480739
  14. Puspita DS. Hubungan lama hemodialisis dengan pasien gagal ginjal di RS PKU Muhammadiyah Yogyakarta (Disertasi). Yogyakarta; 2015 http://digilib.unisayogya.ac.id/162/1/Naskah%20Publikasi.pdf
  15. Zyga S, Alikari V, Sachlas A, Stathoulis J, Aroni A, Theofilou P, et al. Original article management of pain and quality of life in patients with chronic kidney disease undergoing hemodialysis. Pain Manag Nurs. American Society for Pain Management Nursing. 2015;1–9. https://doi.org/10.1016/j.pmn.2015.03.004
  16. Khairiadi. Korelasi derajat depresi dengan skor kualitas hidup penderita penyakit ginjal kronis di RSUP Dr.Kariadi Semarang. Universitas Diponegoro; 2012
  17. Ackland P. Prevalence, detection, evaluation and management of chronic kidney disease. ABC of kidney disease. 2013;15-22. https://doi.org/10.1136/bmj.f7688
  18. Ash S, Campbell K, Bogard J, Millichamp A. Nutrion prescription to achive positive outcome in crhonic kidney disease. A systemic review. 2014;6(1):416-451. https://doi.org/10.3390/nu6010416
  19. Berezin AE. Osteopontin in vascular calcification: A central player or accidental witness? Med Chem. 2017;7(4):844-845. DOI: 10.4172/2161-0444.1000439
  20. Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis. Acta Clin Belg. 2016;71:38-45. doi: 10.1080/17843286.2015.1110894
  21. Kaleta B. The role of osteopontin in kidney diseases. Inflamm res. 2018;68(2):93-102. https://doi.org/10.1007/s00011-018-1200-5
  22. Ishaq NO, Ismail OM. The effect of hemodialysis on calcium and magnesium level among chronic renal failure patients. IJAR. 2016;4(12):1893-1897. http://dx.doi.org/10.21474/IJAR01/2598
  23. Zheng CM, Lu KC, Chia-Chao WC, Ho Hsu, Feng Lin. Association of serum phosphate and related factors in ESRD-related vascular calcification. International Journal of Nephrology. 2011;1-8. http://dx.doi.org/10.4061/2011/939613
  24. Shaarawy AB, Hosny M, Raafat M, Gendy N. Study of cardic valvular calcification in esrd patients on regular hemodialysis (a single center study). The EGHM. 2012;47:190 – 216. DOI: 10.12816/ejhm.2012.16291

How to Cite

Barliyan, M. A., Samsuria, I. K., & Rahayu, M. (2020). Hubungan antara osteopontin dengan rasio Ca : Mg dan nilai Ca X P: Studi pada penderita penyakit ginjal tahap akhir. Intisari Sains Medis, 11(3), 1293–1297. https://doi.org/10.15562/ism.v11i3.611
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
113

Total
126

Share

Search Panel

Muh Agus Barliyan
Google Scholar
Pubmed
ISM Journal

Indranila Kustarini Samsuria
Google Scholar
Pubmed
ISM Journal

Muji Rahayu
Google Scholar
Pubmed
ISM Journal